Some evidence indicated that AD‐related pathology would first occur in the olfactory bulbs and tracts, where amyloid‐β protein (Aβ), tau, and α‐synuclein are concentrated (Schofield, Finnie, & Yong, 2014). Here, MAPT is linked to Alzheimer disease.